LotusPharm
Snaevar Vidisson is Director of Export Markets, B2B. He joined the Company in October 2017 and is responsible for commercial operations and out-licensing in China, Japan and all ex.APAC markets globally. Snaevar built up the commercial operations for the Lotus export business from scratch from the first international B2B launch in 2017 and is currently running 200+ out-licensing deals covering more than 160 countries with over 300 SKU’s launched. Prior to joining the Company, Snaevar worked at Credit Suisse AG, Switzerland.
Snaevar holds a Master’s degree in Financial Risk Management from University College London and a Bachelor degree in Financial Engineering from Reykjavik University, Iceland.
This person is not in any offices
LotusPharm
2 followers
Alvogen is the next generation pharmaceuticals company. Our business model ensures competitive advantage through focused in-house capabilities and a network of partners for enhanced speed and flexibility. Alvogen currently has commercial operations in ...